Portfolio Management Services (PMS)Compare Schemes
KEDIA - Multi Cap vs Valcreate Lifesciences and Specialty Opportunities
Add SchemeGrowth of ₹1 Crore
KEDIA - Multi Cap
Valcreate Lifesciences and Specialty Opportunities
Return for the risk
3 yrs return
5%
10%
15%
20%
25%
Nifty 500 · 12.1%
10%
20%
30%
Volatility • 3 yrs deviation
1 Month
2.23%
6.35%
6 Months
7.97%
17.95%
1 Year
6.21%
21.71%
3 Years
12.78%
19.34%
5 Years
14.19%
—
Since Inception
16.41%
19.34%
Fund Age
7 yrs 3 mo
3 yrs 6 mo
AUM
₹115.97 Cr
₹18.73 Cr
Alpha – 1 Year
1.49%
16.99%
Alpha – 3 Years
0.69%
7.25%
Information Ratio – 3 Years
0.20
0.85
Volatility – 1 Year
15.75%
22.22%
Volatility – 3 Years
15.69%
20.72%
Beta – 1 Year
0.82
0.87
Beta – 3 Years
0.88
0.89
Sharpe Ratio – 1 Year
0.12
0.75
Sharpe Ratio – 3 Years
0.51
0.85
Worst Rolling Year
11.84%
—
Value at Worst Rolling Year
₹1.12 Cr
—
Deepest Drawdown
−23.37%
—
Recovery Period
Not yet recovered
—
1-Year Rolling Windows Positive
100.00%
—
Median Rolling Year
21.02%
—
5-Year Rolling Windows Positive
100.00%
—
Market-Cap Mix
—
—
Number of Stocks
35
—
Portfolio P/E
—
—
Top 5 Holdings
—
Sharda Cropchem Ltd · 11.13%
Kwality Pharmaceuticals Ltd · 5.72%
Sumitomo Chemical India Ltd · 5.72%
Vinati Organics Ltd · 5.51%
Rallis India Ltd · 5.34%
Top Sectors
—
—
Fixed Fee
1.00% / yr
2.50% / yr
Performance Fee / Plan
20% of profit, above 10%
Fixed Plan
Exit Load (Y1 / Y2 / Y3)
0% / 0% / 0%
0% / 0% / 0%